Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Healthcare Biotechnology
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 - ACAD

PR Newswire April 29, 2015

ALERT: Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals Inc. and of the LP Deadline of May 12, 2015 -- ACAD

GlobeNewswire April 29, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline -- ACAD

GlobeNewswire April 24, 2015

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Acadia Pharmaceuticals Inc. and a Lead Plaintiff Deadline of May 12, 2015

Business Wire April 21, 2015

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In ACADIA Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire April 20, 2015

Lifshitz & Miller Law Firm Announces Investigation of Acadia Pharmaceuticals Inc., Akorn, Inc., Dover Saddlery, Inc., Excel Trust, Inc., Informatica Corporation, Inogen, Inc. and Zep, Inc.

PR Newswire April 20, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015

Business Wire April 15, 2015

ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015

Business Wire April 7, 2015

Hagens Berman Reminds ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD) Investors With Over $100,000 in Losses of May 12th Lead Plaintiff Deadline

GlobeNewswire April 7, 2015

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - ACAD

GlobeNewswire April 6, 2015

Cohen Milstein Sellers & Toll PLLC Announces the Investigation of ACADIA Pharmaceuticals, Inc.

GlobeNewswire April 6, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 -- ACAD

GlobeNewswire April 6, 2015

IMPORTANT ANNOUNCEMENT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Federal Securities Class Action Has Been Filed Against ACADIA Pharmaceuticals Inc. in the United States District Court for the Southern District of California -- ACAD

GlobeNewswire March 27, 2015

ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors

Business Wire March 26, 2015

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In ACADIA Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire March 25, 2015

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals, Inc. -- ACAD

GlobeNewswire March 24, 2015

Hagens Berman Alerts ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD) Investors With Over $100,000 in Losses of May 12th Lead Plaintiff Deadline

GlobeNewswire March 23, 2015

ACADIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc.

Business Wire March 20, 2015

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $50,000 Investing in Acadia Pharmaceuticals, Inc. (ACAD) to Contact the Firm

Marketwired March 18, 2015

ACADIA Pharmaceuticals Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire March 18, 2015